USPTO serial 99288952
METRA
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- MAIHOS, JESSIE ANDREA
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with METRA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $549*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | (Based on Section 44(e)) Medical and veterinary preparations, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the maintenance, preservation, treatment, and transplant of organs; medical and veterinary preparations for use with organs ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the maintenance, preservation, treatment, and transplant of organs; perfusion solutions for transplant organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the maintenance, preservation, treatment, and transplant of organs; perfusion solutions for organs in vivo and ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the maintenance, preservation, treatment, and transplant of organs; therapeutic preparations for organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the maintenance, preservation, treatment, and transplant of organs; medical and veterinary preparations for the perfusion of organs, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the maintenance, preservation, treatment, and transplant of organs; nutrition for organs ex vivo, namely, perfusion fluids containing minerals, salts, vitamins, amino acids, proteins, enzymes for use with organs in vivo and ex vivo; pharmaceuticals for treating organs in vivo or ex vivo, namely, perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use in the maintenance, preservation, treatment, and transplant of organs; perfusion preparations in the nature of pharmaceutical solutions for medical, veterinary and clinical use for maintaining and improving the quality of organs in vivo or ex vivo; biological preparations for the treatment and maintenance of organs inside or outside human or animal bodies | ACTIVE | — |
| 009 | (Based on Section 1(b)) Downloadable and recorded software applications for use with medical, veterinary and clinical devices, apparatus and equipment, to facilitate the remote access and control of the medical, veterinary and clinical devices, apparatus and equipment | ACTIVE | — |
| 010 | (Based on Section 44(e)) Medical and veterinary apparatus and instruments, namely, system for use in human and animal organ support; medical and veterinary apparatus and instruments for preserving organs and body parts; medical and veterinary apparatus for perfusing organs inside or outside human or animal bodies; medical and veterinary apparatus for the transportation of organs; medical and veterinary apparatus for enabling functional assessment of donor transplant organs during storage and transportation; medical and veterinary apparatus for ex vivo organs , namely, a device for stabilizing organ temperature for medical purposes; replacement parts and fittings for the aforesaid goods | ACTIVE | — |
| 042 | (Based on Section 1(b)) Software as a service (SaaS) featuring software for use with medical, veterinary and clinical devices, apparatus and equipment, to facilitate the remote access and control of the medical, veterinary and clinical devices, apparatus and equipment; providing online nondownloadable software for use with medical, veterinary and clinical devices, apparatus and equipment, to facilitate the remote access and control of the medical, veterinary and clinical devices, apparatus and equipment; consultancy services relating to computer software | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OrganOx Limited
- Other trademarks owned by OrganOx Limited
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named METRA
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 11, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 11, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 5, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 29, 2026 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jul 12, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 20, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 20, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 20, 2026 | ALIE | ASSIGNED TO LIE | — |
| Apr 15, 2026 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Apr 13, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 13, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 13, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 19, 2026 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Mar 19, 2026 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Feb 24, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 24, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 24, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 21, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 21, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 5, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 18, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 18, 2025 | NWAP | NEW APPLICATION ENTERED | — |